Unfortunately, there is still insufficient data to argue that these retroviral and lentiviral-free induced pluripotent stem cell are safe for clinical application. Accordingly, further in vitro and in vivo, animal, studies are necessary to develop optimized growth and differentiation protocols and reliable safety assays to evaluate the potential of induced pluripotent stem cells and induced pluripotent stem cells-derived differentiated cells for clinical application in patients